Fundraising Fox

Sea Pharmaceuticals

Cambridge, US · Founded 2013 · Iowa LLC · 1 known investors

Biotech

Founders & leadership

JP
James P. PearsonPRESIDENT, CHIEF EXECUTIVE OFFICER, CHIEF SCIENCE OFFICER
MH
Michael HigginsManager
EO
Eric OlsonManager
WK
W. Kendall BrownManager
BC
Benjamin CravattManager
EJ
Eduardo J. MartinezVice President
NE
Nabil ElkouhDirector
ER
ERIC R OLSONDirector
MF
MICHAEL F. HIGGINSDirector
SS
Shaker SadasivamDirector
MG
MARK G. CURRIEDirector
WK
WALTER KENDALL BROWNDirector

Investors · 1

Iaso VenturesreportedCambridgevia Mark G. Currie · board

Reported raises · per SEC filings

Form D private placements
▶$71.1KraisedMay 2026 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark G. CurrieDirector
  • Shaker SadasivamDirector
  • James P. PearsonExecutive Officer, Director
  • Nabil ElkouhDirector
  • Michael J. HigginsDirector
  • Walter Kendall BrownDirector
  • Eric R OlsonDirector
Offering amount
$1.7M
Amount sold
$71.1K
Minimum investment
$7.5K
Proceeds to insiders
$150K
First sale
Jul 2025
Incorporated
Limited Liability Company, Iowa
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$417.4KraisedFeb 2025 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • NABIL J. ELKOUHDirector
  • ERIC R OLSONDirector
  • MICHAEL F. HIGGINSDirector
  • SHAKER SADASIVAMDirector
  • MARK G. CURRIEDirector
  • JAMES P PEARSONExecutive Officer, Director
  • WALTER KENDALL BROWNDirector
Offering amount
$2.2M
Amount sold
$417.4K
Minimum investment
$7.5K
Proceeds to insiders
$150K
First sale
Dec 2023
Incorporated
Limited Liability Company, Iowa
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedJan 2023 · 27 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Benjamin F. CravattDirector
  • Eric R. OlsonDirector
  • Michael HigginsDirector
  • Nabil ElkouhDirector
  • Mark G. CurrieDirector
  • Shaker SadasivamDirector
  • James P. PearsonExecutive Officer, Director
  • Walter Kendall BrownDirector
Offering amount
$2M
Amount sold
$1.5M
Minimum investment
$6.5K
Proceeds to insiders
$150K
First sale
Mar 2019
Incorporated
Limited Liability Company, Iowa
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MofferedNov 2017 · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Nabil ElkouhDirector
  • Eric R. OlsonDirector
  • James P. PearsonExecutive Officer, Director
  • W. Kendall BrownDirector
  • Shaker SadasivamDirector
  • Anne M. SullivanExecutive Officer
  • Benjamin F. CravattDirector
  • Michael J. HigginsDirector
  • Eduardo J. MartinezExecutive Officer
Offering amount
$2M
Minimum investment
$5K
Incorporated
Limited Liability Company, Iowa, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$887KraisedNov 2016 · 38 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James P. PearsonExecutive Officer, Director
  • Michael HigginsDirector
  • Eric OlsonDirector
  • Nabil ElkouhDirector
  • Shaker SadasivamDirector
  • W. Kendall BrownDirector
  • Benjamin CravattDirector
  • Eduardo J. MartinezExecutive Officer
Offering amount
$3.5M
Amount sold
$887K
Minimum investment
$5K
First sale
Feb 2016
Incorporated
Limited Liability Company, Iowa, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.